As a product owner, I am responsible for the android hospital logistics solution, with reception, storage, requisition, picking, consumption, returns and inventory flows, and one of the people responsible for the new microservices platform (Mozy).

As a healthcare consultant, I was responsible for implementing integrated medicine management system solutions in hospitals.

As a member of this institute, and within the scope of the project, I investigated, in in vitro models of microglia cells (BV2), mechanisms associated with neuroinflammation in the context of exposure of adult animals to methylmercury toxicity.

As a member of the Vectors and Gene Therapy research group, and within the scope of the project, I implemented a combined strategy, involving the manipulation of microRNAs and siRNAs and the lipidome of glioblastoma cells, using Stable Nucleic Acid Lipid Particles (SNALPs), to increase the susceptibility of this cancer to new generation chemotherapeutic agents (e.g., Axitinib) and thus contributing to the eradication of this pathology.

For my MSc thesis, I joined the Vectors and Gene Therapy research group, and within the scope of the project, I established and characterized human Pluripotent Stem Cells derived Brain Organoids to model Machado‑Joseph Disease (MJD), concretely, whole‑brain organoids from human induced Pluripotent Stem Cells (hiPSCs), and midbrain/hindbrain organoids from human Neuroepithelial Stem Cells (hNESCs).